As per MRFR analysis, the India Gene Editing Market Size was estimated at 287.6 (USD Million) in 2023. The India Gene Editing Market Industry is expected to grow from 400 (USD Million) in 2024 to 3,100 (USD Million) by 2035. The India Gene Editing Market CAGR (growth rate) is expected to be around 20.461% during the forecast period (2025 - 2035).
The India Gene Editing Market is expanding at a rapid pace due to a variety of factors. Increasing demand for precision medicine and the prevalence of genetic disorders are the primary market drivers. Interest in gene editing has also been stimulated by government initiatives that are designed to improve agricultural productivity by utilizing advanced biotechnological methods.
The National Biotechnology Development Strategy and policies that encourage research and development in the agricultural sector are creating an environment that is favorable for gene editing applications. The Indian gene editing market offers a plethora of opportunities, particularly in the fields of agriculture and healthcare. Gene editing technologies can be instrumental in the development of crops that are resistant to pests, diseases, and adverse climatic conditions, given the extensive agricultural landscape and the increasing emphasis on food security.
Additionally, advancements in gene editing have the potential to create personalized treatment options for patients with genetic diseases, thereby facilitating the development of healthcare solutions that are specifically designed for the Indian population. In recent years, there has been a growing trend of collaboration between academia and industry stakeholders to advance gene editing research.
The Indian Council of Agricultural Research and numerous institutions are currently involved in projects that utilize CRISPR and other gene editing technologies to improve the characteristics of crops. Furthermore, the market dynamics are being positively impacted by the public's increasing acceptance of genetically modified organisms (GMOs), which is paving the way for gene editing applications that promise sustainable agricultural practices and higher yields.
In the global gene editing landscape, India is on the brink of becoming a significant participant, capitalizing on its skilled workforce and diverse biodiversity to drive innovation. This is due to the maturation of regulations surrounding gene editing.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The rapid advancement in genetic research and development (R&D) is significantly driving the India Gene Editing Market. India has emerged as a hotspot for biotechnology innovation, with over 40 biotechnology parks and numerous research institutions dedicated to gene editing technologies.
According to the Biotechnology Industry Research Assistance Council (BIRAC), investments in biotechnological research in India have tripled in the last decade, highlighting the increasing emphasis on genetic studies and Innovation. This has led to enhanced focus on gene therapies, genetically modified organisms, and agricultural biotechnology, positioning India to be a significant player in the global gene editing landscape.
Additionally, companies like Syngenta and Bayer are actively engaged in collaborations with Indian institutions, advancing gene editing projects, particularly in agriculture. This collaborative environment is expected to bolster the growth of the India Gene Editing Market as more institutions and organizations prioritize genetic research to address both health and agricultural challenges.
The rising incidence of genetic disorders and diseases in India is a critical factor propelling the India Gene Editing Market. According to the Ministry of Health and Family Welfare, around 1.5 million children are born each year in India with genetic disorders, which represent a considerable burden on healthcare systems.
This alarming statistic serves as a strong motivator for R&D in gene editing, as it promises novel therapeutic solutions. Organizations like the Indian Council of Medical Research (ICMR) have initiated various programs aimed at understanding and combating genetic disorders through innovative approaches, including CRISPR technology. This urgency for therapeutic options is fostering collaborations and investments in gene editing technologies, thus promoting the growth of the market.
The Indian government is actively supporting biotechnology initiatives, which catalyzes the India Gene Editing Market Industry's expansion. The Department of Biotechnology (DBT) revealed plans to allocate approximately USD 1.5 billion toward biotech innovation and infrastructure improvement over the next five years.
Such initiatives not only enhance funding for Research and Development but also foster an ecosystem conducive to gene editing breakthroughs. Programs aimed at facilitating public-private partnerships and providing grants have encouraged numerous startups and established companies in India to explore gene editing technologies, fostering a competitive environment. The involvement of governmental organizations like the Indo-US Science and Technology Forum (IUSSTF) in funding research collaborations further emphasizes the growing state support for innovations in gene editing.
The Technology segment of the India Gene Editing Market plays a pivotal role in advancing the capabilities and applications of gene editing techniques across various fields, including medicine, agriculture, and industrial biotechnology. Among the various technologies, CRISPR has garnered significant attention due to its simplicity, versatility, and cost-effectiveness, allowing for precise modification of genes, which presents opportunities for advancements in genetic research and therapeutic developments.
TALEN technology is noted for its reliability in targeted gene editing, making it essential for creating genetically modified organisms that can withstand pests and diseases, thus enhancing food security important factor for a country like India, where agricultural productivity is paramount.
ZFN, while sometimes overshadowed by newer technologies, remains a valuable tool for gene regulation and gene therapy applications, contributing to India's growing focus on biotechnology innovation. Antisense technology is being explored for its potential in treating genetic disorders by targeting specific RNA molecules, showcasing the adaptability and breadth of applications that gene editing technologies have in addressing public health challenges.
While the current emphasis on these technologies presents immense growth potential, the market also faces challenges such as regulatory hurdles, ethical concerns, and the need for skilled personnel in the rapidly evolving landscape of gene editing. Ultimately, these dynamics in the Technology segment of the India Gene Editing Market underline how critical these advancements are for the future of biotechnology within the country, aligning with India’s ambitions to become a leader in genetic research and its applications, thus solidifying the importance of these technologies for various sectors and society at large.
The integration of these gene editing technologies not only promises innovations that can aid in crop improvement, disease resistance, and targeted therapies but also offers substantial socio-economic benefits by addressing pressing environmental and health issues faced in the region.
Source: Primary Research, Secondary Research, MRFR Database, and Analyst Review
The Application segment of the India Gene Editing Market is experiencing notable growth as countries focus on advancing their biotechnological capabilities. This segment encompasses various areas such as Genetic Engineering, Gene Therapy, Cell Line Engineering, and others, which play crucial roles in addressing healthcare, agricultural, and industrial challenges.
Genetic Engineering has proved essential in developing genetically modified organisms to enhance crop resilience and yield, thus ensuring food security in a populous nation like India. Gene Therapy stands out with its potential to treat genetic disorders, thus transforming patient outcomes and reducing the burden on healthcare systems.
Cell Line Engineering is significant for its use in drug discovery and development, allowing researchers to create more effective therapeutics. Furthermore, other applications are expanding rapidly as innovative technologies emerge, particularly in the pharmaceutical and agricultural sectors.
Collectively, these segments underscore the potential of the India Gene Editing Market to drive advancements in health and agriculture, aligning with national initiatives in biotechnology and sustainable development. This growth is fueled by government support and increasing investment in Research and Development across these applications, highlighting their critical importance within the overall framework of the genetic landscape in India.
The Method segment of the India Gene Editing Market encompasses innovative approaches that are pivotal to advancing the biotechnology field. The two primary categories within this segment are Ex-vivo and In-vivo techniques. Ex-vivo methods involve manipulating genes outside of the organism, making them crucial for applications in cell therapy and regenerative medicine, where precision is paramount.
This approach allows for enhanced control over genetic modifications before reintegrating the edited cells back into the patient, thereby offering significant therapeutic advantages. Conversely, In-vivo editing involves direct modifications within the organism, which is gaining traction due to its potential for addressing genetic disorders without the need for extensive manipulation of cells outside the body.
Both approaches are significantly contributing to the growth of gene therapies in India, driven by rising investments in Research and Development and a supportive regulatory environment. The expanding agricultural sector is also exploring these gene editing methods to enhance crop traits, reflecting the versatility of the technology in addressing various challenges.
As a result, the Method segment is positioned to play a crucial role in shaping the future landscape of the India Gene Editing Market, catering to healthcare, agriculture, and beyond.
The end-user segment of the India Gene Editing Market plays a crucial role in driving innovation and development within the sector. Predominantly, Biotechnology and Pharmaceutical Companies are at the forefront, leveraging gene editing technologies to advance drug development, personalized medicine, and therapeutic solutions.
Their significant investment in Research and Development not only accelerates the commercialization of novel treatments but also strengthens the overall market dynamics. Contract Research Organizations (CROs) contribute substantially by providing essential research services, optimizing trial management, and lowering the operational costs associated with drug testing, thereby enhancing the efficiency of research activities for their clients.
Academic and Government Research Institutes are vital for fostering collaboration and ensuring access to the latest advancements in gene editing. These institutions often engage in pioneering research, offering foundational insights that pave the way for practical applications in healthcare and agriculture. The synergy among these end users is instrumental in propelling the growth of the India Gene Editing Market by addressing critical challenges in genetic research and application, ultimately leading to transformative solutions for various healthcare needs in the region.
The India Gene Editing Market is gradually emerging as a critical player in the global biotechnology landscape, characterized by dynamic advancements in research and an increasing focus on agricultural improvement and healthcare solutions. The competitive landscape is shaped by numerous players ranging from established biopharmaceutical companies to innovative startups that are exploring CRISPR technology and other gene editing tools.
This market is influenced by government regulations, funding opportunities, and collaborations that emphasize ethical considerations and sustainability in gene editing applications. With the ongoing research initiatives and rising investment in biotechnological innovations, the future of the gene editing sector in India showcases significant potential for growth and diversification.
Editas Medicine has made notable strides in the India Gene Editing Market through its innovative gene editing solutions, focusing on various therapeutic applications. The company is recognized globally for its pioneering research in CRISPR technology, particularly in treating genetic disorders and diseases through targeted editing approaches.
In India, Editas Medicine emphasizes collaborations with local research institutions and universities to leverage regional expertise and advancements in biotech. The company's strengths lie in its robust intellectual property portfolio, highly skilled research teams, and strategic partnerships that enable rapid development and commercialization of innovative therapies tailored for the Indian market.
These collaborative efforts enhance Editas Medicine's capabilities for localizing its gene editing technologies to address specific health challenges faced by the Indian population. The Indian Agricultural Research Institute operates at the forefront of the India Gene Editing Market, focusing primarily on agricultural biotechnology.
It is renowned for its commitment to enhancing crop productivity and resilience through cutting-edge gene editing techniques. The key products and services offered by the Indian Agricultural Research Institute include genetically modified crops, research on plant genomics, and the development of disease-resistant varieties.
The organization's strengths encompass a strong research foundation, extensive expertise in plant breeding, and active collaborations with other agricultural research organizations, which enhance its market presence. Moreover, its continued dedication to addressing food security in India demonstrates its strategic importance in the agricultural sector.
Mergers and acquisitions with other research institutions further strengthen its capabilities and foster innovation, thereby reinforcing its position as a leader in advancing gene editing applications within Indian agriculture.
Editas Medicine and other key players are actively contributing to advancements in the India Gene Editing Market, which has seen significant investments and research initiatives recently. The Indian Agricultural Research Institute has been leveraging gene editing technologies to enhance crop resilience, impacting agricultural productivity.
Bharat Biotech has been in the news for its focus on gene editing for vaccine development, underscoring the merging of biotechnology with healthcare. Additionally, the Genome Valley in Hyderabad has emerged as an innovation hub, attracting global companies like Ginkgo Bioworks and Thermo Fisher Scientific looking to collaborate and expand their operations in gene editing and synthetic biology.
Syngenta and Corteva Agriscience are also key contributors, pushing the envelope towards sustainable agricultural practices through genetic advancements. In terms of mergers and acquisitions, there have been discussions concerning collaborations and partnerships within the sector, although no significant transactions have been publicly reported in the past months.
The market valuation of companies involved in gene editing has been on the rise, reflecting increased interest and investment towards the genetic modification of crops and therapeutics in response to growing food security and health challenges faced in India.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 287.6(USD Million) |
| MARKET SIZE 2024 | 400.0(USD Million) |
| MARKET SIZE 2035 | 3100.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 20.461% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Editas Medicine, Indian Agricultural Research Institute, Bharat Biotech, Amgen, Caribou Biosciences, Genome Valley, Novozymes, Syngenta, Ginkgo Bioworks, Thermo Fisher Scientific, Corteva Agriscience, Biocon, Mondelez International |
| SEGMENTS COVERED | Technology, Application, Method, End User |
| KEY MARKET OPPORTUNITIES | CRISPR technology adoption, Agricultural biotechnology advancements, Personalized medicine development, Regulatory framework improvement, Disease-resistant crops demand |
| KEY MARKET DYNAMICS | Technological advancements, Regulatory challenges, Increasing funding, Growing agricultural applications, Rising healthcare demand |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Gene Editing Market is expected to be valued at 400.0 USD Million in 2024.
By 2035, the India Gene Editing Market is projected to reach a value of 3100.0 USD Million.
The expected CAGR for the India Gene Editing Market from 2025 to 2035 is 20.461%.
The CRISPR technology segment holds the largest market share, valued at 160.0 USD Million in 2024.
The CRISPR segment is expected to reach a value of 1240.0 USD Million by 2035.
Key players in the market include Editas Medicine, Bharat Biotech, Amgen, and Syngenta among others.
The TALEN technology is anticipated to have a market size of 100.0 USD Million in 2024.
Opportunities in this market include advancements in agricultural applications and therapeutics.
The ZFN segment is expected to be valued at 60.0 USD Million in 2024.
Emerging trends such as personalized medicine and genetic modification in agriculture will drive market growth significantly.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
